Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy.

about

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.

P2860

Q55037788-1BE5B798-7C2A-433B-908A-58AD474FCA93

P2860

Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy.

Item

http://www.wikidata.org/entity/Q47896111

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@en

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@nl

type

Item

label

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@en

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@nl

prefLabel

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@en

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@nl

P1476

Soluble ST2 is associated with ...... ht ventricular cardiomyopathy.

@en

P2093

Ida S Leren

http://www.w3.org/2001/XMLSchema#string

Jørg Saberniak

http://www.w3.org/2001/XMLSchema#string

Kaspar Broch

http://www.w3.org/2001/XMLSchema#string

Kristina H Haugaa

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members.

Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.

Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.

Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography.

Imaging assessment of ventricular mechanics.

P304

367-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1354750X.2016.1278266

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thor Ueland

Thor Edvardsen

Lars Gullestad

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28067540

http://www.w3.org/2001/XMLSchema#string

P921

arrhythmogenic right ventricular cardiomyopathy

Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy.

about

P2860

P2860

Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921